| 注册
首页|期刊导航|临床肝胆病杂志|巨噬细胞糖酵解在代谢相关脂肪性肝病中的调控作用

巨噬细胞糖酵解在代谢相关脂肪性肝病中的调控作用

常嘉涵 蔡玉洁 侯艺鑫 韩聚强

临床肝胆病杂志2025,Vol.41Issue(10):2130-2135,6.
临床肝胆病杂志2025,Vol.41Issue(10):2130-2135,6.DOI:10.12449/JCH251025

巨噬细胞糖酵解在代谢相关脂肪性肝病中的调控作用

Regulatory role of macrophage glycolysis in metabolic dysfunction-associated fatty liver disease

常嘉涵 1蔡玉洁 1侯艺鑫 2韩聚强1

作者信息

  • 1. 中国人民解放军总医院第七医学中心日间诊疗科,北京 100700
  • 2. 首都医科大学附属北京地坛医院中西医结合中心,北京 100015
  • 折叠

摘要

Abstract

Metabolic dysfunction-associated fatty liver disease(MAFLD)is a common chronic liver disease in clinical practice,and macrophages are directly involved in the development,progression,and prognosis of MAFLD.Studies have confirmed that glucose metabolic reprogramming in macrophages directly affects immune function,which in turn affects the local inflammatory environment of liver and hepatocyte metabolism.This article reviews the changes in glucose metabolism of macrophages and the corresponding key molecules in the pathogenesis of MAFLD,in order to provide new targets and strategies for the prevention and treatment of MAFLD in the future.

关键词

代谢相关脂肪性肝病/巨噬细胞/糖酵解/代谢重编程

Key words

Metabolic Dysfunction-Associated Fatty Liver Disease/Macrophages/Glycolysis/Metabolic Reprogramming

引用本文复制引用

常嘉涵,蔡玉洁,侯艺鑫,韩聚强..巨噬细胞糖酵解在代谢相关脂肪性肝病中的调控作用[J].临床肝胆病杂志,2025,41(10):2130-2135,6.

基金项目

国家自然科学基金(81970512) National Natural Science Foundation of China(81970512) (81970512)

临床肝胆病杂志

OA北大核心

1001-5256

访问量0
|
下载量0
段落导航相关论文